Summary of Current Randomized Controlled Trials Evaluating Cinnamon Use in Diabetic Patients
| Author, Date (Reference) | Number of Patients and Setting | Dose of Cinnamon | Placebo | Duration of Trial | Findings |
|---|---|---|---|---|---|
| Khan et al, 2003 (6) | 60 Pakistani adults >40 years of age with many exclusions and mean fasting glucose of 200–250 | 1, 3, or 6 g | Yes | 40 days | Glucose decreased 18% to 29% LDL cholesterol decreased 7% to 27% |
| Vanschoonbeek et al, 2006 (7) | 25 Dutch postmenopausal women with many exclusions and mean HbA1C of 7.1% to 7.4% | 1.5 g | Yes | 6 weeks | No change in HbA1C No change in lipids |
| Mang et al, 2006 (8) | 79 German adults with many exclusions and mean HbA1C of 6.7% to 6.9% | 3 g | Yes | 4 months | Glucose decreased 10.3% |
| Altschuler et al, 2007 (9) | 72 US adolescent patients with type 1 diabetes and mean HbA1C of 8.4% to 8.7% | 1 g | Yes | 90 days | No change in HbA1C |
| Blevins et al, 2007 (10) | 58 US adults with many exclusions and mean HbA1C of 7.1% to 7.2% | 1 g | Yes | 3 months | No change in glucose No change in HbA1C No change in lipids |
LDL, low-density lipoprotein; HbA1C, hemoglobin A1C.